The American Association for the Advancement of Science, or AAAS, on Nov. 25 named 338 new fellows, including Pew biomedical scholars James Bliska (1994), M. Bishr Omary (1989), and Richard Padgett (1986). AAAS fellows are selected based on their demonstrated efforts to advance science or its applications.More info
''NIH names Dr. Gary H. Gibbons director of the National Heart, Lung, and Blood Institute''
National Institutes of Health Director Francis S. Collins M.D., Ph.D., announced today the selection of Gary H. Gibbons, M.D., as the new director of the NIH's National Heart, Lung, and Blood Institute (NHLBI). Dr. Gibbons is the founder and current director of the Cardiovascular Research Institute, chairperson of the Department of Physiology, and professor of physiology and medicine at the Morehouse School of Medicine in Atlanta. He expects to start his new position in the summer of 2012.
Gibbons' institute at Morehouse is recognized for its discovery science related to cardiovascular health of minority populations. His laboratory is focused on discovering novel mediators of vascular disease. His program involves collaborative efforts to study the functional significance of genomic variation and changes in gene activities due to 'epigenetic' modifications of DNA that do not involve a change in the genetic code, as factors that enhance the susceptibility to cardiovascular disease.
"It is my sincere pleasure to welcome Dr. Gibbons to the NIH team," said Collins. His extraordinary scientific skills, tremendous energy and bold vision will be an asset to NHLBI and NIH." Susan B. Shurin, M.D., will continue as acting director of NHLBI until Gibbons joins, at which point she will resume her role as the institute's deputy director. "I want to extend my deep gratitude to Susan for her strong leadership in this role," added Collins.
Gibbons will oversee the third largest institute at the NIH, with an annual budget of more than $3 billion and a staff of 917 federal employees. Gibbons will also direct his own lab at the NIH, focusing on predictive health and genomic medicine in minority populations. The NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
"It's an honor to join the NIH and lead the Heart, Lung, and Blood Institute," said Gibbons. "The globally recognized research and training supported by the NHLBI continues to advance biomedical knowledge in fields related to heart, lung, and blood diseases. I look forward to working with the institute staff and with the many researchers supported by the Institute to foster multidisciplinary approaches to improve disease prevention, diagnosis, and treatment that will advance the health of all Americans."
Gibbons has served as a member of the National Heart, Lung, and Blood Advisory Council (NHLBAC) since 2009, a position he resigned after being selected to be director of the NHLBI. He was also a member of the NHLBI Board of Extramural Experts, a working group of the NHLBAC. Gibbons has received 15 NHLBI-supported grants since 1997.
Under his leadership of the Cardiovascular Research Institute at the Morehouse School of Medicine, Gibbons directed NIH-supported research in the fields of vascular biology, genomic medicine, and the pathogenesis of vascular diseases. During his tenure, the Cardiovascular Research Institute emerged as a center of excellence, leading the way in discoveries related to the cardiovascular health of minority populations. Gibbons has received several patents for innovations derived from his research in the fields of vascular biology and the pathogenesis of vascular diseases.
Gibbons, who is originally from Philadelphia, earned his undergraduate degree from Princeton University in Princeton, N.J., and graduated magna cum laude from Harvard Medical School in Boston. He completed his residency and cardiology fellowship at the Harvard-affiliated Brigham and Women's Hospital in Boston. Prior to joining the Morehouse School of Medicine in 1999, Dr. Gibbons was a member of the faculty at Stanford University, in Stanford, Calif., from 1990 until1996, and Harvard Medical School from 1996 until 1999.
Throughout his career, Gibbons has received numerous honors, including election to the Institute of Medicine of the National Academies of Sciences; selection as a Robert Wood Johnson Foundation Minority Faculty Development Fellowship awardee; selection as a Pew Biomedical Scholar by the Pew Charitable Trusts; and recognition as an Established Investigator of the American Heart Association (AHA).
Dr. Gibbons also serves on several editorial boards for journals in cardiovascular medicine, the Juvenile Diabetes Foundation, and the AHA.
* * *Full Article
- Date added:
- Apr 5, 2012
Gregory Amberg, a 2010 Pew scholar and assistant professor of biomedical sciences at Colorado State University, has won a $1.8 million grant from the National Institutes of Health to study how high blood pressure develops in people with obesity. With the five-year award, Amberg hopes to identify the underlying causes for the cardiovascular disease, with the aim of developing therapies to prevent its organ-damaging effects.More info
Manu Prakash, a 2013 Pew scholar and assistant professor of bioengineering at Stanford University, has been awarded a Grand Challenges Explorations Grant from the Bill & Melinda Gates Foundation. As one of 81 winners selected from more than 2,700 proposals, Prakash’s team will develop an inexpensive electromagnetic detection device to diagnose infections of parasitic worms in people.More info
June Round, a 2013 Pew scholar and assistant professor of Pathology at the University of Utah, has been awarded the 2013 Packard Fellowship in Science and Engineering. As one of 16 scientists selected to receive the $875,000 grant, Round will focus her research on bacteria in the gut—working to identify strategies to kill the disease-causing kind while maintaining “good” kind.More info
Deborah Hung, a 2007 Pew scholar, was featured in a podcast by the Proceedings of the National Academy of Sciences of the United States of America called “Changing the way we think about antibiotics”. As an assistant professor at the Richard B. Simches Research Center at Massachusetts General Hospital, Hung’s work explores new avenues to treat and diagnose infectious diseases like tuberculosis.More info
This month, the Nobel Prize in Chemistry was announced, directing global attention to the importance of chemical studies. The winners—Martin Karplus, Michael Levitt, and Arieh Warshel—were recognized for developing some of the first computer models for complex systems of molecules.More info
Winrich Freiwald, a 2010 Pew scholar and assistant professor at The Rockefeller University, is one of seven scientists receiving $1.5 million for cutting-edge neuroscience research as he establishes his laboratory. Past awardees include Vanessa Ruta, a 2012 Pew scholar and assistant professor at Rockefeller.More info
"The Pew Charitable Trusts last March named Assistant Professor of Biomedical Engineering Qiaobing Xu a Pew Scholar for his biomedical research on a new method of promoting nerve growth."More info
Mark Andermann, a 2013 Pew Scholar and assistant professor at Beth Israel Deaconess Medical Center, conducts innovative research to determine the changes in the brain triggered by hunger and external food cues. Watch the video to learn more about how his work is shedding light on obesity and eating disorders.More info
The Daily Californian ran an article covering the research of Diana Bautista, a 2009 Pew scholar and assistant professor at University of California, Berkeley, who led in research discovering a way to relieve the itch of eczema and ward off some of its worst symptoms. The study, published in Cell, demonstrated that blocking the activity of nerve cells in the skin could stop the itch and inflammation associated with the condition—which affects 10 percent of the population.More info
2011 Pew biomedical scholar Michael Kuhns studies the processes leading to immunity in vertebrates and researches how cells communicate with each other to induce the appropriate immune response to an invading pathogen or a vaccine.More info
Qioabing Xu, an assistant professor of biomedical engineering at Tufts University, has identified a method to use organic collagen to create replacement nerve tissue. His innovations differs from most similar nerve-repair mechanisms, which use expensive inorganic materials.More info
Randy Schekman, a professor at of molecular and cell biology at the University of California, Berkeley, shares the 2013 Nobel Prize for Physiology and Medicine with Yale University’s James Rothman and Stanford University’s Thomas Südhof. Schekman—who served on the national advisory committee for Pew’s scholars program from 1996 to 2002—was recognized for discovering a set of genes required for the transport of molecules within cells.More info